What Next | Daily News and Analysis

TBD | The Rise of Off-Brand Ozempic

GLP-1 drugs like Ozempic and Wegovy are in high demand and short supply. The internet makes it easy for you to have a compounding pharmacy whip you up a batch—but should you?

Guest: Kate Knibbs, senior writer at Wired. 

Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The problem with the news right now? It’s everywhere. And each day, it can feel like we’re all just mindlessly scrolling. It’s why we created What Next. This short daily show is here to help you make sense of things. When the news feels overwhelming, we’re here to help you answer: What next? Look for new episodes every weekday morning.